*Personal Opinion* The company received great and positive news this morning about their product in phase 2 (AGO13). They will present interim data on AGO13 at the European Society of Medical Oncology Congress on Sept 27th to Oct 1st of 2019. All these data is positive so I'm expecting an increase of the SP during EOW or by the end of the next week. The Chart looks good in my opinion and the stock didn't increased that much today because of the lo 900k aprox. The stock have good news and a decent chart, all it need is .
-Important- ! Don't buy because of my study, do your own DD !